Home » Top Tips » Prescriptions and Medications » Medications » What Are the 10 Most Common Antidepressants?

What Are the 10 Most Common Antidepressants?

Save article
[favorite_button post_id="" site_id=""]
Pharmacy, medicine and box with healthcare shop, shelf and prescription care pills.
This is how the AI article summary could look. Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

What Are the 10 Most Common Antidepressants?

Selecting the right antidepressant involves balancing therapeutic benefits against side effect profiles.

Below is a clinical overview of the 10 most effective medications for Major Depressive Disorder (MDD), Anxiety, and related conditions.


1. Selective Serotonin Reuptake Inhibitors (SSRIs)

SSRIs are typically the first-line treatment due to their safety profile and broad efficacy.

  • Sertraline (Zoloft): The “all-rounder.” Highly effective for depression combined with high-anxiety or OCD.

    • Side Effects: GI upset, insomnia, sexual dysfunction.

  • Escitalopram (Lexapro): Known for being “highly selective” with fewer drug-to-drug interactions.

    • Side Effects: Nausea, fatigue, increased sweating.

  • Fluoxetine (Prozac): Notable for its long half-life (approx 4-6 days), making it safer for patients who occasionally miss a dose.

    • Side Effects: Tremors, nervousness (activation), weight loss.

  • Citalopram (Celexa): A reliable, cost-effective SSRI. Requires monitoring of the QT interval (heart rhythm) at higher doses.

    • Side Effects: Dry mouth, sleepiness.

  • Paroxetine (Paxil): Stronger sedative effect compared to other SSRIs; highly effective for panic disorder.

    • Side Effects: Weight gain, significant withdrawal symptoms if stopped abruptly.

2. Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs)

SNRIs are often used when SSRIs are insufficient, particularly for depression involving low energy or physical pain.

  • Venlafaxine (Effexor): Excellent for “treatment-resistant” cases. It acts on serotonin at low doses and norepinephrine at higher doses.

    • Side Effects: Increased blood pressure, dizziness, nausea.

  • Duloxetine (Cymbalta): The gold standard for Dual-Indication (treating both depression and chronic physical pain).

    • Side Effects: Constipation, decreased appetite, dry mouth.

3. Atypical & Tricyclic Antidepressants

These medications are used for specific patient needs, such as insomnia or treatment-resistant depression.

  • Mirtazapine (Remeron): A NaSSA that is highly sedating.

    • Key Benefit: Best for patients with insomnia or underweight issues.

    • Side Effects: Significant weight gain, increased appetite, sedation.

  • Trazodone (Desyrel): Technically a SARI; nowadays primarily used as a non-habit-forming sleep aid for depressed patients.

    • Side Effects: Daytime grogginess, orthostatic hypotension.

  • Amitriptyline (Elavil): An older Tricyclic (TCA). It is extremely potent but carries more side effects than modern drugs.

    • Best for: Migraine prevention and severe, refractory depression.

    • Side Effects: Blurred vision, weight gain, constipation.


Comparison Summary: Best Fit by Symptom

If the patient has… Recommended Treatment (Example)
High Anxiety Sertraline or Escitalopram
Chronic Pain Duloxetine
Insomnia / Low Weight Mirtazapine
Panic Disorder Paroxetine
Difficulty with Compliance Fluoxetine (long half-life)

Clinical Best Practices for Success

  1. Latency of Action: Patients must be counseled that mood improvements typically take 4 to 8 weeks, though sleep and appetite may improve sooner.

  2. Titration Strategy: “Start low and go slow” to minimize early-onset side effects and increase long-term adherence.

  3. Black Box Warning: Closely monitor patients under 25 for increased suicidal ideation during the first few weeks of therapy.

  4. The Tapering Protocol: To avoid Antidepressant Discontinuation Syndrome, doses should be reduced gradually over several weeks under medical supervision.

Clinical Note: Treatment should be individualised. If a patient does not respond to a first-line SSRI, switching to a different class (like an SNRI) or augmenting with psychotherapy is often recommended.


Summary

Finding the right medication for Major Depressive Disorder (MDD) is rarely a “one-size-fits-all” process.

Whilst efficacy rates are often similar across drug classes, the “best” antidepressant is usually defined by how well a patient tolerates its specific side effect profile.

Related Posts

Share this article

Your feedback matters to us!

Comments

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    myHSN is here to help you get the best you can out of the NHS.

    Full of top tips and advice from health care professionals on how the NHS works and how you can make sure it works for you.
    Copyright © 2025 Health Service Navigator